药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Anisindione
PEV3A
The therapeutic efficacy of PEV3A can be decreased when used in combination with Apremilast.
Anisindione
G17DT
The therapeutic efficacy of G17DT can be decreased when used in combination with Apremilast.
Anisindione
Osimertinib
The serum concentration of Osimertinib can be decreased when it is combined with Apremilast.
Anisindione
Lobeglitazone
The metabolism of Apremilast can be decreased when combined with Lobeglitazone.
Anisindione
Simeprevir
The metabolism of Apremilast can be decreased when combined with Simeprevir.
Anisindione
Pazufloxacin
The metabolism of Apremilast can be decreased when combined with Pazufloxacin.
Anisindione
Cyproterone acetate
The metabolism of Cyproterone acetate can be increased when combined with Apremilast.
Anisindione
Fingolimod
Apremilast may increase the immunosuppressive activities of Fingolimod.
Anisindione
Abiraterone
The serum concentration of Abiraterone can be increased when it is combined with Apremilast.
Anisindione
Riociguat
Apremilast may increase the hypotensive activities of Riociguat.
Anisindione
Teriflunomide
The serum concentration of Apremilast can be decreased when it is combined with Teriflunomide.
Anisindione
Deferasirox
The serum concentration of Apremilast can be increased when it is combined with Deferasirox.
Anisindione
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Apremilast.
Anisindione
Roflumilast
Apremilast may increase the immunosuppressive activities of Roflumilast.
Anisindione
Difluocortolone
The risk or severity of adverse effects can be increased when Apremilast is combined with Difluocortolone.
Anisindione
Clobetasol
The risk or severity of adverse effects can be increased when Apremilast is combined with Clobetasol.
Anisindione
Fluocortolone
The risk or severity of adverse effects can be increased when Apremilast is combined with Fluocortolone.
Anisindione
Hydrocortisone succinate
The risk or severity of adverse effects can be increased when Apremilast is combined with Hydrocortisone succinate.
Anisindione
Mometasone furoate
The risk or severity of adverse effects can be increased when Apremilast is combined with Mometasone furoate.
Anisindione
Tetrandrine
The risk or severity of adverse effects can be increased when Apremilast is combined with Tetrandrine.